NVDA
56
-4
CSCO
67
4
BSX
67
-3
EBAY
47
4
SO
53
-4
EXC
53
-3
STI
14
-17
VNO
60
10
GIS
31
3
ACN
52
3
MA
64
7
NRG
49
-3
BAC
53
3
RIG
60
2
TDC
80
4
PAYX
53
2
MLM
57
6
WBA
48
4
PSA
58
2
M
37
12
NVDA
56
-4
CSCO
67
4
BSX
67
-3
EBAY
47
4
SO
53
-4
EXC
53
-3
STI
14
-17
VNO
60
10
GIS
31
3
ACN
52
3
MA
64
7
NRG
49
-3
BAC
53
3
RIG
60
2
TDC
80
4
PAYX
53
2
MLM
57
6
WBA
48
4
PSA
58
2
M
37
12
Financhill
Back

Intelligent Bio Solutions 10K Form

Sell
34

INBS
Intelligent Bio Solutions

Last Price:
1.55
Seasonality Move:
-29.31%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive INBS News And Ratings

See the #1 stock for the next 7 days that we like better than INBS

INBS Financial Statistics

Sales & Book Value

Annual Sales: $3.11M
Cash Flow: $-2.39M
Price / Cash Flow: 0
Annual Sales: $1.39
Price / Book: 1.11

Profitability

EPS (TTM): -35.47570
Net Income (TTM): $-10.42M
Gross Margin: $1.43M
Return on Equity: -176.44%
Return on Assets: -86.71%

Intelligent Bio Solutions Earnings Forecast

Key Intelligent Bio Solutions Financial Ratios

  • The Gross Profit Margin over the past 3 years for INBS is 45.81%.
  • The Selling, General & Administrative Expenses for INBS have been equal to 297.53% of Gross Profit Margin.
  • The Research & Development expenses have been 53.79% of Revenue.
  • The Interest Expense is -1.65% of Operating Income.
  • The Net Earning history of INBS is -326.40% of Total Revenues.
  • Per Share Earnings over the last 7 years have been positive in 4 years.

Intelligent Bio Solutions Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: INBS
Website: gbs.inc

Debt

Debt-to-Equity Ratio: 0.08
Current Ratio: 1.14
Quick Ratio: 0.92

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

INBS Technical Analysis vs Fundamental Analysis

Sell
34
Intelligent Bio Solutions (INBS) is a Sell

Is Intelligent Bio Solutions a Buy or a Sell?